USANA Health Sciences (NYSE: USNA) reported Q3 EPS of ($0.15), $0.71 worse than the analyst estimate of $0.56. Revenue for the quarter came in at $214 million versus the consensus estimate of $224.97 million.

GUIDANCE:

USANA Health Sciences sees FY2025 EPS of $0.78, versus the consensus of $1.70. USANA Health Sciences sees FY2025 revenue of $920 million, versus the consensus of $919.6 million.

For earnings history and earnings-related data on USANA Health Sciences (USNA) click here.